Pazopanib exposure in advanced soft tissue and bone sarcoma: A pharmacokinetic/pharmacodynamic analysis

被引：1
|
作者：
Minot, M-S. [1 ]
Rouquette, P. Boudou [1 ]
Jouinot, A. [2 ]
Balakirouchenane, D. [3 ]
Tlemsani, C. [1 ]
De Percin, S. [4 ]
Chen, J. [1 ]
Meyo, M. Tiako [1 ]
Thomas-Schoemann, A. [1 ]
Goldwasser, F. [1 ]
Blanchet, B. [3 ]
Alexandre, J. [1 ]
机构：
[1] Hop Cochin, AP HP, Oncol, Site Port Royal, Paris, France
[2] Hop Cochin, AP HP, INSERM, Site Port Royal, Paris, France
[3] Hop Cochin, AP HP, Pharmacol, Paris, France
[4] Hop Cochin, Hop Univ Paris Ctr, Med Oncol, Paris, France
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.879
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1549P
引用
收藏
页码：S1125 / S1125
页数：1
相关论文
共 50 条
  • [1] Pazopanib In Advanced Soft Tissue Sarcoma
    Deeks, Emma D.
    [J]. DRUGS, 2012, 72 (16) : 2129 - 2140
  • [2] PAZOPANIB FOR ADVANCED SOFT TISSUE SARCOMA
    Takamori, H.
    Karasuno, T.
    Nishiura, N.
    [J]. ANNALS OF ONCOLOGY, 2013, 24
  • [3] Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group retrospective analysis
    Kollar, A.
    Jones, R. L.
    Stacchiotti, S.
    Gelderblom, H.
    Guida, M.
    Boccone, P.
    Steeghs, N.
    Safwat, A.
    Katz, D.
    Duffaud, F.
    Sleijfer, S.
    van sder Graaf, W.
    Touati, N.
    Litiere, S.
    Marreaud, S.
    Gronchi, A.
    Kasper, B.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [4] Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis
    Kollar, A.
    Jones, R. L.
    Stacchiotti, S.
    Gelderblom, H.
    Guida, M.
    Grignani, G.
    Steeghs, N.
    Safwat, A.
    Katz, D.
    Duffaud, F.
    Sleijfer, S.
    van der Graaf, W. T.
    Touati, N.
    Litiere, S.
    Marreaud, S.
    Gronchi, A.
    Kasper, B.
    [J]. ACTA ONCOLOGICA, 2017, 56 (01) : 88 - 92
  • [5] RETROSPECTIVE SAFETY ANALYSIS IN ADVANCED SOFT TISSUE SARCOMA PATIENTS OF PAZOPANIB HYDROCHLORIDE
    Kawasaki, K.
    Hamamoto, Y.
    Sakai, G.
    Funakoshi, S.
    Higuchi, H.
    Takaishi, H.
    Kitagawa, Y.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 : 65 - 65
  • [6] Targeted treatment for advanced soft tissue sarcoma: profile of pazopanib
    Rajendra, Rajeev
    Jones, Robin L.
    Pollack, Seth M.
    [J]. ONCOTARGETS AND THERAPY, 2013, 6 : 217 - 222
  • [7] Genomic analysis of predictive biomarker for pazopanib treatment in patients with advanced soft tissue sarcoma
    Sekimizu, Masaya
    Asano, Naofumi
    Mitani, Sachiyo
    Yamazaki, Fumito
    Kubo, Takashi
    Yoshida, Akihiko
    Kobayashi, Eisuke
    Iwata, Shintaro
    Kamoda, Hiroto
    Yonemoto, Tsukasa
    Inagaki, Katsunori
    Kawai, Akira
    Ichikawa, Hitoshi
    [J]. CANCER SCIENCE, 2018, 109 : 294 - 294
  • [8] Pazopanib as new therapeutic option in therapy of advanced soft tissue sarcoma
    Jagiello-Wieczorek, Ewelina
    Switaj, Tomasz
    Jagielska, Beata
    Falkowski, Slawomir
    Rutkowski, Piotr
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 (01): : 24 - 31
  • [9] Pazopanib in the treatment of soft tissue sarcoma
    Schoeffski, Patrick
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (06) : 711 - 723
  • [10] Pazopanib in the advanced and rare subtypes of soft tissue sarcoma: Russian Sarcoma Group study.
    Tararykova, Anastasia Alekseevna
    Bokhyan, Beniamin
    Konev, Andrey A.
    Falkina, Polina A.
    Kumekhov, Zaur Yu.
    Valiev, Aslan K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345